Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1940932

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1940932

Medical Devices Reimbursement Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 189 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

The global Medical Devices Reimbursement Market is experiencing significant growth, driven by the rising adoption of advanced medical technologies, evolving healthcare policies, and increasing insurance coverage worldwide. The market is expected to reach USD 812.6 billion in 2026 and expand to USD 1,334.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of 6.2% over the forecast period. Reimbursement policies are vital for ensuring patient access to medical devices, supporting healthcare providers, and promoting innovation in medical technology.

Reimbursement for medical devices enables healthcare systems to deliver cost-effective solutions while ensuring that manufacturers and providers maintain sustainable revenue streams. Growing government initiatives and insurance programs across the globe are further boosting the uptake of medical devices, improving overall patient care.

Market Insights

The medical devices reimbursement market covers a broad spectrum of devices used across hospitals, physician offices, and diagnostic laboratories. Demand is primarily fueled by the increasing prevalence of chronic diseases, aging populations, and the need for cost-efficient healthcare services.

Currently, North America leads the market due to its mature reimbursement infrastructure, widespread insurance coverage, and high adoption of advanced medical devices. Europe follows closely, supported by favorable policies and public-private reimbursement programs. Meanwhile, the Asia Pacific region is emerging as a high-growth market owing to expanding healthcare infrastructure, rising insurance penetration, and increasing awareness of advanced medical technologies.

The market is highly dynamic and sensitive to regulatory changes, pricing pressures, and technological innovations. Effective reimbursement systems are essential for ensuring that medical devices are accessible to patients at affordable costs while supporting manufacturers' growth.

Market Drivers

The growth of the medical devices reimbursement market is propelled by several key factors:

  • 1. Rising Healthcare Expenditure - Governments and private healthcare providers are investing heavily in medical devices, driving demand for reimbursement services.
  • 2. Increasing Prevalence of Chronic Diseases - Conditions such as cardiovascular diseases, diabetes, and cancer require advanced diagnostic and therapeutic devices, increasing the need for reimbursement.
  • 3. Technological Advancements - Innovations in minimally invasive procedures, wearable devices, and diagnostic equipment are boosting adoption under reimbursement frameworks.
  • 4. Supportive Policies and Regulations - Reimbursement processes are being streamlined by governments and insurers, improving patient access and promoting device adoption.
  • 5. Shift Towards Outpatient and Homecare Settings - The growing trend of decentralized healthcare has created demand for devices reimbursed in non-hospital environments.

Business Opportunities

The market presents multiple opportunities for stakeholders:

  • Enhanced Payer Engagement - Insurers can expand coverage for a broader range of devices, increasing patient access.
  • Provider Collaboration - Hospitals, diagnostic labs, and physician offices can leverage reimbursement to improve healthcare delivery.
  • Technology Integration - Digital health tools and telemedicine can streamline claims processing, reduce administrative burdens, and improve efficiency.
  • Emerging Market Potential - Asia Pacific, Latin America, and the Middle East & Africa offer significant growth due to increasing healthcare investment, insurance adoption, and government reimbursement programs.

Regional Analysis

  • North America: Dominates the market due to robust reimbursement frameworks, high healthcare expenditure, and widespread adoption of advanced medical technologies.
  • Europe: Growth supported by government initiatives, public-private reimbursement programs, and increasing device adoption in hospitals and outpatient care.
  • Asia Pacific: Fastest-growing region due to rising healthcare awareness, increasing insurance penetration, and government investments in healthcare infrastructure.
  • Latin America: Moderate growth driven by evolving reimbursement policies, private healthcare expansion, and increased government support.
  • Middle East & Africa: Emerging opportunities due to rising healthcare infrastructure investments, increasing insurance coverage, and growing adoption of advanced devices.

Key Players

The market is highly competitive, with leading medical device manufacturers, insurers, and healthcare providers actively shaping growth. Prominent players include:

  • Medtronic
  • Johnson & Johnson
  • Abbott Laboratories
  • Boston Scientific
  • Siemens Healthineers
  • GE Healthcare
  • Philips Healthcare
  • Stryker Corporation
  • Zimmer Biomet
  • Becton, Dickinson and Company (BD)
  • UnitedHealth Group
  • CVS Health / Aetna
  • Cigna Corporation
  • Humana Inc.
  • Allianz / Aviva / WellCare Health Plans

These organizations are focusing on strategic partnerships, mergers, and collaborations to expand reimbursement networks, increase market reach, and foster innovation in medical device technology.

Market Segmentation

By Claims:

  • Underpaid
  • Full Paid

By Application:

  • Public Payers
  • Private Payers

By Service Provider:

  • Physician Office
  • Hospitals
  • Diagnostic Laboratories
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Medical Devices Reimbursement Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Fiver Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Medical Devices Reimbursement Market Outlook, 2020-2033

  • 3.1. Global Medical Devices Reimbursement Market Outlook, by Claims, Value (US$ Bn), 2020-2033
    • 3.1.1. Underpaid
    • 3.1.2. Full Paid
  • 3.2. Global Medical Devices Reimbursement Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 3.2.1. Public payers
    • 3.2.2. Private payers
  • 3.3. Global Medical Devices Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2020-2033
    • 3.3.1. Physician Office
    • 3.3.2. Hospitals
    • 3.3.3. Diagnostic Laboratories
    • 3.3.4. Others
  • 3.4. Global Medical Devices Reimbursement Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Medical Devices Reimbursement Market Outlook, 2020-2033

  • 4.1. North America Medical Devices Reimbursement Market Outlook, by Claims, Value (US$ Bn), 2020-2033
    • 4.1.1. Underpaid
    • 4.1.2. Full Paid
  • 4.2. North America Medical Devices Reimbursement Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 4.2.1. Public payers
    • 4.2.2. Private payers
  • 4.3. North America Medical Devices Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2020-2033
    • 4.3.1. Physician Office
    • 4.3.2. Hospitals
    • 4.3.3. Diagnostic Laboratories
    • 4.3.4. Others
  • 4.4. North America Medical Devices Reimbursement Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 4.4.2. U.S. Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 4.4.3. U.S. Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 4.4.4. Canada Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 4.4.5. Canada Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 4.4.6. Canada Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Medical Devices Reimbursement Market Outlook, 2020-2033

  • 5.1. Europe Medical Devices Reimbursement Market Outlook, by Claims, Value (US$ Bn), 2020-2033
    • 5.1.1. Underpaid
    • 5.1.2. Full Paid
  • 5.2. Europe Medical Devices Reimbursement Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 5.2.1. Public payers
    • 5.2.2. Private payers
  • 5.3. Europe Medical Devices Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2020-2033
    • 5.3.1. Physician Office
    • 5.3.2. Hospitals
    • 5.3.3. Diagnostic Laboratories
    • 5.3.4. Others
  • 5.4. Europe Medical Devices Reimbursement Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 5.4.2. Germany Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 5.4.3. Germany Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 5.4.4. Italy Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 5.4.5. Italy Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 5.4.6. Italy Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 5.4.7. France Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 5.4.8. France Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 5.4.9. France Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 5.4.10. U.K. Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 5.4.11. U.K. Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 5.4.12. U.K. Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 5.4.13. Spain Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 5.4.14. Spain Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 5.4.15. Spain Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 5.4.16. Russia Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 5.4.17. Russia Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 5.4.18. Russia Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 5.4.19. Rest of Europe Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 5.4.20. Rest of Europe Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 5.4.21. Rest of Europe Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Medical Devices Reimbursement Market Outlook, 2020-2033

  • 6.1. Asia Pacific Medical Devices Reimbursement Market Outlook, by Claims, Value (US$ Bn), 2020-2033
    • 6.1.1. Underpaid
    • 6.1.2. Full Paid
  • 6.2. Asia Pacific Medical Devices Reimbursement Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 6.2.1. Public payers
    • 6.2.2. Private payers
  • 6.3. Asia Pacific Medical Devices Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2020-2033
    • 6.3.1. Physician Office
    • 6.3.2. Hospitals
    • 6.3.3. Diagnostic Laboratories
    • 6.3.4. Others
  • 6.4. Asia Pacific Medical Devices Reimbursement Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 6.4.2. China Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 6.4.3. China Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 6.4.4. Japan Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 6.4.5. Japan Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 6.4.6. Japan Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 6.4.7. South Korea Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 6.4.8. South Korea Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 6.4.9. South Korea Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 6.4.10. India Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 6.4.11. India Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 6.4.12. India Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 6.4.13. Southeast Asia Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 6.4.14. Southeast Asia Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 6.4.15. Southeast Asia Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 6.4.16. Rest of SAO Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 6.4.17. Rest of SAO Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 6.4.18. Rest of SAO Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Medical Devices Reimbursement Market Outlook, 2020-2033

  • 7.1. Latin America Medical Devices Reimbursement Market Outlook, by Claims, Value (US$ Bn), 2020-2033
    • 7.1.1. Underpaid
    • 7.1.2. Full Paid
  • 7.2. Latin America Medical Devices Reimbursement Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 7.2.1. Public payers
    • 7.2.2. Private payers
  • 7.3. Latin America Medical Devices Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2020-2033
    • 7.3.1. Physician Office
    • 7.3.2. Hospitals
    • 7.3.3. Diagnostic Laboratories
    • 7.3.4. Others
  • 7.4. Latin America Medical Devices Reimbursement Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 7.4.2. Brazil Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 7.4.3. Brazil Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 7.4.4. Mexico Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 7.4.5. Mexico Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 7.4.6. Mexico Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 7.4.7. Argentina Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 7.4.8. Argentina Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 7.4.9. Argentina Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 7.4.10. Rest of LATAM Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 7.4.11. Rest of LATAM Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 7.4.12. Rest of LATAM Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Medical Devices Reimbursement Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Medical Devices Reimbursement Market Outlook, by Claims, Value (US$ Bn), 2020-2033
    • 8.1.1. Underpaid
    • 8.1.2. Full Paid
  • 8.2. Middle East & Africa Medical Devices Reimbursement Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 8.2.1. Public payers
    • 8.2.2. Private payers
  • 8.3. Middle East & Africa Medical Devices Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2020-2033
    • 8.3.1. Physician Office
    • 8.3.2. Hospitals
    • 8.3.3. Diagnostic Laboratories
    • 8.3.4. Others
  • 8.4. Middle East & Africa Medical Devices Reimbursement Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 8.4.2. GCC Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 8.4.3. GCC Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 8.4.4. South Africa Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 8.4.5. South Africa Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 8.4.6. South Africa Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 8.4.7. Egypt Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 8.4.8. Egypt Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 8.4.9. Egypt Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 8.4.10. Nigeria Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 8.4.11. Nigeria Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 8.4.12. Nigeria Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
    • 8.4.13. Rest of Middle East Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
    • 8.4.14. Rest of Middle East Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
    • 8.4.15. Rest of Middle East Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Medtronic
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Johnson & Johnson
    • 9.4.3. Abbott Laboratories
    • 9.4.4. Boston Scientific
    • 9.4.5. Siemens Healthineers
    • 9.4.6. GE Healthcare
    • 9.4.7. Philips Healthcare
    • 9.4.8. Stryker Corporation
    • 9.4.9. Zimmer Biomet
    • 9.4.10. Becton, Dickinson and Company (BD)

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!